We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.31B
1-Year Est. Return 18.36%
This Fund
S&P 500
This Quarter Est. Return
-11.63%
1 Year Est. Return
+18.36%
3 Year Est. Return
+53.76%
5 Year Est. Return
+60.8%
10 Year Est. Return
+204.74%
AUM
$1.35B
AUM Growth
-$150M
Cap. Flow
+$56.3M
Cap. Flow %
4.16%
Top 10 Hldgs %
19.09%
Holding
2,522
New
117
Increased
687
Reduced
642
Closed
145

Sector Composition

Rank Sector Weight
1 Technology 5.94%
2 Energy 5.6%
3 Industrials 5.47%
4 Healthcare 5.28%
5 Financials 5.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLQD icon
1026
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.38B
$58K ﹤0.01%
1,173
+973
+487% +$48.1K
BSCO
1027
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
$58K ﹤0.01%
2,930
WWE
1028
DELISTED
World Wrestling Entertainment
WWE
$58K ﹤0.01%
+800
New +$60.1K
RNDM
1029
DELISTED
First Trust Developed International Equity Select ETF
RNDM
$58K ﹤0.01%
1,300
PSXP
1030
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
$58K ﹤0.01%
1,398
+4
+0.3% +$194
AVNS
1031
DELISTED
Avanos Medical
AVNS
$57K ﹤0.01%
1,337
EXG icon
1032
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$3.04B
$57K ﹤0.01%
7,638
PBP icon
1033
Invesco S&P 500 BuyWrite ETF
PBP
$361M
$57K ﹤0.01%
2,952
PWB icon
1034
Invesco Large Cap Growth ETF
PWB
$2.42B
$57K ﹤0.01%
1,390
+1,300
+1,444% +$57.7K
TAL icon
1035
TAL Education Group
TAL
$6.65B
$57K ﹤0.01%
2,160
-540
-20% -$14.3K
TVRD
1036
Tvardi Therapeutics
TVRD
$19M
$57K ﹤0.01%
125
-37
-23% -$23.9K
CC icon
1037
Chemours
CC
$2.7B
$56K ﹤0.01%
2,049
-108
-5% -$3.42K
FREL icon
1038
Fidelity MSCI Real Estate Index ETF
FREL
$1.5B
$56K ﹤0.01%
2,509
KINS icon
1039
Kingstone Companies
KINS
$294M
$56K ﹤0.01%
3,100
LH icon
1040
Labcorp
LH
$25.3B
$56K ﹤0.01%
524
-152
-22% -$20.4K
ZTS icon
1041
Zoetis
ZTS
$31.9B
$56K ﹤0.01%
664
+335
+102% +$30.2K
ICPT
1042
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$56K ﹤0.01%
600
+100
+20% +$10.4K
ACA icon
1043
Arcosa
ACA
$7.13B
$55K ﹤0.01%
+2,008
New +$55.2K
FTXO icon
1044
First Trust Nasdaq Bank ETF
FTXO
$314M
$55K ﹤0.01%
2,500
+1,600
+178% +$41.1K
ICLR icon
1045
Icon
ICLR
$12.1B
$55K ﹤0.01%
440
-79
-15% -$10.9K
RPM icon
1046
RPM International
RPM
$14.7B
$55K ﹤0.01%
956
+101
+12% +$6.19K
SPGI icon
1047
S&P Global
SPGI
$122B
$55K ﹤0.01%
330
+62
+23% +$11.1K
VTWV icon
1048
Vanguard Russell 2000 Value ETF
VTWV
$1.32B
$55K ﹤0.01%
598
DRE
1049
DELISTED
Duke Realty Corp.
DRE
$55K ﹤0.01%
2,190
-238
-10% -$6.6K
ASHR icon
1050
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.56B
$54K ﹤0.01%
2,477
-34,488
-93% -$803K

Similar funds

Geneos Wealth Management's Q4 2018 Portfolio in Review

As of Q4 2018, Geneos Wealth Management held 2,522 positions worth $1.35B, down 10% from $1.5B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Geneos Wealth Management deployed $56.3M of net new capital in Q4 2018, opening 117 new positions and adding to 687 existing holdings. Its largest new stake was Vanguard Russell 1000 Growth ETF: 26,240 shares worth $872K.

By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.5% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $9.44M trimmed.

  • Geneos Wealth Management's largest Q4 2018 buy was Vanguard Russell 1000 Growth ETF: 26,240 shares worth $872K.
  • Geneos Wealth Management added most to iShares Russell 1000 ETF in Q4 2018, an estimated $16M increase.
  • Geneos Wealth Management's biggest Q4 2018 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $9.44M.
  • Geneos Wealth Management fully exited ProShares Ultra Consumer Discretionary in Q4 2018, selling an estimated $4.08M.
  • Geneos Wealth Management's ten largest holdings make up 19% of its $1.35B portfolio in Q4 2018.
  • Geneos Wealth Management opened 117 new positions and closed 145 in Q4 2018.
  • Geneos Wealth Management's portfolio value fell 10% quarter-over-quarter to $1.35B.

Based on Geneos Wealth Management's 13F filing for Q4 2018, filed 7 Sep 2021.